ajanta pharma: Promoter group entities to sell 4.6% stake in Ajanta Pharma via block deal Thursday
Related Posts
Limited’s promoter group entities Ayush Agarwal Trust and Ravi Agarwal Trust plan to together sell 4.6% stake in the drugmaker through a block deal on Thursday, according to reports.
Through the sale, the entities are looking at raising close to Rs 650 crore. The minimum price they plan to offer for the sale is Rs 1,113, a 5% discount to the current market price.
On Wednesday, shares of Ajanta Pharma ended 0.6% higher on the National Stock Exchange at Rs 1,171.80.
As of September 30, the total promoter group holding in the company stood at 70.5%. Of this, the two promoter group entities together held 28.73% stake. Jefferies has been appointed as the broker to conduct the transaction.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)
Denial of responsibility! TechnoCodex is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – [email protected]. The content will be deleted within 24 hours.
